The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF Multi-stakeholder Workshops in 2023

Save the date for the CDDF Multi-Stakeholder workshops and the Annual Conference in 2023!


The leading non-competitive drug development platform working to
stimulate the advancement and accessibility of cancer treatment.

Join the CDDF Office Team – Event Coordinator

[CDDF Office: Job vacancy - Event Coordinator] The CDDF is seeking an event coordinator to assist with the organization and delivery of programmes and events, ranging from small workshops and a yearly conference to webinars. Join the CDDF team and work together with...


[READ KEY TAKEAWAYS FROM THE CDDF WEBINAR] The Cancer Drug Development Forum (CDDF) held a live webinar on the topic of regulatory considerations for Immunotherapy and Radiotherapy Combinations on Monday 27 February 2023. Here are the key takeaways from Prof Paz...

Interviews with the CDDF’s Key Stakeholders

The Cancer Drug Development Forum (CDDF) greatly values all stakeholders’ voices and engagement which help the oncology community break down silos and continue open, meaningful dialogue. To accelerate oncology drug development and deliver optimal treatment to cancer...

CDDF Annual Conference 2023: Executive Summary

📢 The Cancer Drug Development Forum (CDDF) is delighted to inform you that its executive summary of the Annual Conference 2023 has been published and is available to all our stakeholders. The 2023 edition of the multi-stakeholder conference took place on 6-8 February...

CDDF Annual Conference – Day 3

Closing the Annual Conference 2023, we would like to thank all our stakeholders for their engagement and support for our shared mission to improve effective cancer treatment and empower patients. For those interested in our discussion during the last session,...

CDDF Annual Conference 2023 – Day 2

We invite you to take a look at the take-home messages and next steps from yesterday's sessions. SESSION 3: WHAT I SHOULD HAVE ASKED WHEN I STARTED MY CARREER IN CANCER DRUG DEVELOPMENT ❇ Take-Home Messages • It is important to consider where you want your career to...

CDDF Annual Conference 2023 – Day 1

Cancer Drug Development Forum (CDDF) opened the Annual Conference 2023 yesterday with more than 150 people joining onsite and online. Here are the Take-Home Messages from the first day of the Annual Conference: • Diversity can be understood as the combination of...

World Cancer Day – Closing the Gap in Cancer Care

Ahead of World Cancer Day (4 February 2023), the Cancer Drug Development Forum (CDDF) would like to turn the spotlight on existing inequalities in cancer care. To improve cancer patients’ equitable access to effective, innovative medicines, the CDDF is fully committed...

[Publication] CDDF’s Meeting Report – Histology Independent Drug Development: Is This Future for Cancer Drugs?

The CDDF’s meeting report from its multi-stakeholder workshop on Histology independent drug development (Nov 2022, NL) has been published today. Discover thought-provoking key takeaways from the interesting sessions and share your thoughts with the CDDF community. To...

Season’s Greetings & Happy Holiday Wishe

🔔⛄ Season's Greetings & Happy Holiday Wishes from the CDDF to all cancer patients, their families, and our stakeholders: In warm appreciation of your support and engagement with the CDDF during the past year, the CDDF extends our very best wishes for a Happy...

CDDF Webinar: Diversity in Clinical Trials (September 2022)

The recording of the recent CDDF webinar on Diversity in Clinical Trials is available here. Enjoy the insightful lectures from Prof. Dr. Marie von Lilienfeld-Toal (University of Jena, DE)  & Dr. Lola Fashoyin-Aje (FDA, US) and our thought-provoking discussion. 

CDDF & Oncology News

Check out the recent updates within the CDDF and the latest news in the community of cancer research

CDDF Brochure

Access the CDDF Brochure here


Join the CDDF community to find ways to accelerate oncology drug development and deliver optimal treatment to cancer patients

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70